May 22, 2024
Cleft Lip Surgery Market

Global Cleft Lip Surgery Market is Estimated to Witness High Growth Owing to Rising Prevalence of Cleft Lip Disorders

Cleft lip surgery, also known as cleft lip repair, is a surgical procedure used for correcting cleft lip, a type of facial birth defect where the lip does not fully form during fetal development leaving an opening in the lip. Cleft lip can occur isolated or in association with cleft palate. Cleft lip surgery aims reconstruct the lip muscle and tissue to improve facial symmetry, repair the abnormal opening, allow normal development of dental arches and provide functional and cosmetic benefits. The advantages of cleft lip surgery at early stages includes better development of dental arches and facial structures for future growth and improved speech. The need for cleft lip surgeries arises due to increasing prevalence of cleft lip disorders globally, associated with genetic factors and environmental causes such as maternal illnesses during pregnancy.

The Global Cleft Lip Surgery Market is estimated to be valued at US$ 450 MN in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Cleft Lip Surgery are Children’s Hospital of Philadelphia, Medanta, Apollo, Great Ormond Street Hospital, The McIndoe Centre, University Hospital Bonn, Louis Children Hospitals, and Care National Hospital.

Key opportunities in the Cleft Lip Surgery Market Demand include growing medical tourism in developing regions due to availability of cost-effective treatments and focus of players on expanding facilities in Asia Pacific and Latin America.

Increasing awareness about cleft lip treatment options globally due to focus of Non-Governmental Organizations is contributing to the expansion of cleft lip surgery market. Players are also looking at opportunities arising from greater healthcare access and spending in developing nations on surgical treatments.

Market drivers

The rising prevalence of cleft lip disorders is a major driver for the global cleft lip surgery market. According to the World Health Organization, an estimated 142,740 newborns are affected by cleft lip and palate each year globally. Genetic factors for cleft lip also contribute to the rising numbers. The other key driver is increasing focus and emphasis on early cleft lip surgeries owing to psychological and functional advantages it offers such as speech development and self-esteem aspects in individuals.

PEST Analysis

Political: Government support in the form of reimbursement and funding for cleft lip surgeries will positively influence the market growth. However, stringent regulations for product approval and high compliance requirements add to the overall costs.

Economic: Rising income levels and growing spending on healthcare are expected to support the market expansion. However, high treatment costs can limit the market penetration in low and middle-income countries.

Social: Increasing social awareness and availability of enhanced surgical procedures are reducing the stigma around craniofacial abnormalities. Support groups are encouraging affected individuals to seek timely treatment.

Technological: Advancements in microsurgeries, grafting techniques and use of imaging aids are improving the outcomes. However, continuous upgradation and training require substantial investments.

Concentration of market by value

North America accounts for the largest share of the global cleft lip surgery market owing to presence of advanced healthcare facilities, awareness levels and high per capita healthcare expenditure in the region. Europe is also among the prominent markets led by availability of government supported universal healthcare in countries.

Fastest growing region

Asia Pacific region is expected to witness rapid market growth during the forecast period attributed to rising incidence of cleft lip and growing medical tourism industry in countries like India, Thailand and South Korea. Improving access to healthcare and rise in private insurance are expanding the reach of quality treatment in Asia Pacific.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it